- Investing Ideas
- U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
U.S. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
9
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
9 companies
Natera
Market Cap: US$40.6b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$281.27
7D
3.6%
1Y
77.5%
AbbVie
Market Cap: US$450.1b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$254.65
7D
1.2%
1Y
34.2%
Travere Therapeutics
Market Cap: US$5.3b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$57.85
7D
1.8%
1Y
278.1%
Mesa Laboratories
Market Cap: US$566.6m
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
MLAB
US$96.16
7D
-3.4%
1Y
4.5%
Sotera Health
Market Cap: US$5.1b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$18.02
7D
1.5%
1Y
55.5%
BioLife Solutions
Market Cap: US$1.4b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$27.93
7D
-2.0%
1Y
25.1%
Waters
Market Cap: US$37.2b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$374.93
7D
-0.03%
1Y
7.8%
SIGA Technologies
Market Cap: US$269.0m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$3.67
7D
0.8%
1Y
-45.8%
Repligen
Market Cap: US$7.9b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$139.83
7D
0.6%
1Y
7.7%